Trials / Not Yet Recruiting
Not Yet RecruitingNCT06845306
The Use of Indocyanine Green Near-infrared Fluorescence for Bowel Perfusion Quantitative Assessment in Order to Prevent Anastomotic Leakage in Colorectal Surgery
Indocyanine Green Near-infrared Fluorescence Bowel Perfusion Quantitative Assessment to Prevent Anastomotic Leakage in Colorectal Surgery: a Multicentre, Randomised, Controlled Study
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 1,268 (estimated)
- Sponsor
- Vadim Kuznetsov · Network
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Anastomotic leakage (AL) is a serious complication after surgery for colon cancer, leading to a significant increase in mortality.Intraoperative fluorescence imaging using indocyanine green has proven to be a feasible and reproducible technique for real-time perfusion assessment. An increasing number of studies are being published on the use of indocyanine green (ICG) fluorescence imaging in colorectal cancer surgery, showing promising results. Therefore, we propose conducting a multicenter, randomized controlled trial to investigate the potential use of quantitative assessment of near-infrared fluorescence imaging with indocyanine green (ICG) to prevent anastomotic leaks during colorectal surgery.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ICG-guided bowel perfusion assessment | ICG will be injected before anastomosis is created, to quantitatively assess the perfusion status of the bowel. |
| OTHER | Conventional Bowel Anastomosis group | conventional perfusion assessment |
Timeline
- Start date
- 2025-06-01
- Primary completion
- 2026-07-01
- Completion
- 2026-09-01
- First posted
- 2025-02-25
- Last updated
- 2025-02-25
Locations
1 site across 1 country: Russia
Source: ClinicalTrials.gov record NCT06845306. Inclusion in this directory is not an endorsement.